Gilaad G Kaplan

InstitutionUniversity of Calgary
AddressCalgary
Alberta
Canada
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in October 2020
    All Publications
    Bar chart showing 212 publications over 17 distinct years, with a maximum of 34 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kaplan GG, Ma C, Charlton C, Kanji JN, Tipples G, Sharifi N, Herauf M, Coward S, Ingram RJM, Hracs L, Benchimol EI, Panaccione R. Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study. Gut. 2021 Aug 02. PMID: 34340997.
      Citations: 2     Fields:    
    2. Uche-Anya E, Husby S, Kaplan GG, Underwood FE, Green PHR, Lebwohl B. An International Reporting Registry of Patients With Celiac Disease and COVID-19: Initial Results From SECURE-CELIAC. Clin Gastroenterol Hepatol. 2021 11; 19(11):2435-2437.e4. PMID: 34146715.
      Citations:    Fields:    Translation:Humans
    3. Agrawal M, Brenner EJ, Yan Mak JW, Zhang X, Kaplan GG, Ng SC, Reinisch W, Steinwurz F, Lewis JD, Kissous-Hunt M, Modesto I, Ungaro RC, Colombel JF, Kappelman MD. COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States. Clin Gastroenterol Hepatol. 2021 10; 19(10):2210-2213.e3. PMID: 34089848.
      Citations:    Fields:    Translation:Humans
    4. Bernstein CN, Ng SC, Banerjee R, Steinwurz F, Shen B, Carbonnel F, Hamid S, Sood A, Yamamoto-Furusho JK, Griffiths A, Benchimol EI, Travis S, Lopes S, Rubin DT, Kaplan GG, Armstrong D, Gearry R. Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey. Inflamm Bowel Dis. 2021 05 17; 27(6):836-847. PMID: 32793973.
      Citations: 5     Fields:    Translation:Humans
    5. Mao R, Rieder F, Ben-Horin S, Kaplan GG, Ng SC, Wong GL, Ghosh S, Chen MH. Implications of COVID-19 for patients with pre-existing digestive diseases: an update. Lancet Gastroenterol Hepatol. 2021 04; 6(4):258-260. PMID: 33539813.
      Citations: 2     Fields:    Translation:Humans
    6. Windsor JW, Underwood FE, Brenner E, Colombel JF, Kappelman MD, Ungaro R, Zhang X, Kaplan GG. Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD Registry. Am J Gastroenterol. 2020 11; 115(11):1923-1924. PMID: 33156119.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    7. Dotan I, Panaccione R, Kaplan GG, O'Morain C, Lindsay JO, Abreu MT. Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force. J Crohns Colitis. 2020 Oct 21; 14(14 Suppl 3):S785-S790. PMID: 32959882.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    8. Ungaro RC, Brenner EJ, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD. Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 2021 04; 70(4):725-732. PMID: 33082265.
      Citations: 79     Fields:    Translation:Humans
    9. Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021 01; 18(1):56-66. PMID: 33033392.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    10. Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 2020 08; 159(2):481-491.e3. PMID: 32425234.
      Citations: 218     Fields:    Translation:HumansCellsPHPublic Health